Mutations in ASXL1 and/or TET2 Identify a Subset with Worse Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasms

被引:0
|
作者
Xu, Mina [1 ]
Thakkar, Devang [2 ]
Panse, Gauri [1 ]
Yan, Jiong [3 ,4 ]
Minden, Mark [5 ]
Zandi, Sasan [6 ]
Naresh, Kikkeri [7 ]
Czader, Magdalena [8 ]
Love, Cassandra [2 ]
Happ, Lanie [9 ]
Koff, Jean [10 ]
Jaye, David [11 ]
Michael, Churnetski [10 ]
Arildsen, Mary Ann [12 ]
Juskevicius, Ridas [13 ]
Soliman, Dina [14 ]
Louissaint, Abner [15 ]
Mckinney, Matthew [2 ]
Sojitra, Payal [16 ]
Yin, C. Cameron [17 ]
Ondrejka, Sarah [18 ]
Tse, Eric [19 ]
Dave, Sandeep [2 ]
机构
[1] Yale Univ, New Haven, CT USA
[2] Duke Univ, Durham, NC USA
[3] Univ Hlth Network, Lab Med Program, Dept Anat Pathol, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Hlth Network, Toronto, ON, Canada
[6] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[7] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[8] Indiana Univ, Indianapolis, IN USA
[9] Data Driven Biosci, Durham, NC USA
[10] Emory Univ, Atlanta, GA USA
[11] Emory Univ, Sch Med, Atlanta, GA USA
[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[13] Pathgroup, Nashville, TN USA
[14] Hamad Med Corp, Doha, Qatar
[15] Massachusetts Gen Hosp, Boston, MA 02114 USA
[16] Univ Med & Dent New Jersey, New Brunswick, NJ USA
[17] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[18] Cleveland Clin, Cleveland, OH USA
[19] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1210
引用
收藏
页码:S1258 / S1259
页数:2
相关论文
共 50 条
  • [21] Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome
    Feng, Yue
    Liang, Haiping
    Han, Meining
    Luo, Xingchun
    Zhu, Yu
    Liu, Bei
    HEMATOLOGY, 2023, 28 (01)
  • [22] Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia
    Cui Y.
    Tong H.
    Du X.
    Li B.
    Gale R.
    Qin T.
    Liu J.
    Xu Z.
    Zhang Y.
    Huang G.
    Jin J.
    Fang L.
    Zhang H.
    Pan L.
    Hu N.
    Qu S.
    Xiao Z.
    Experimental Hematology & Oncology, 4 (1)
  • [23] BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS - UNUSUAL PRESENTATIONS AND UNFAVOURABLE OUTCOMES
    Guenova, M.
    Michova, A.
    Dikov, T.
    Georgieva, Y.
    Spassov, B.
    Prisadashka, K.
    Balabanova, M.
    Kaleva, V.
    Balatzenko, G.
    HAEMATOLOGICA, 2017, 102 : 682 - 682
  • [24] TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
    Soyer, Nur
    Kaymaz, Burcin Tezcanli
    Ozkan, Melda Comert
    Aktan, Cagdas
    Kucukaslan, Ali Sahin
    Sahin, Fahri
    Kosova, Buket
    Saydam, Guray
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) : 174 - 178
  • [25] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    A Tefferi
    Leukemia, 2010, 24 : 1128 - 1138
  • [26] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    Tefferi, A.
    LEUKEMIA, 2010, 24 (06) : 1128 - 1138
  • [27] Sole DNMT3A/TET2/ASXL1 Mutations Define a Distinct Clinical Trajectory for Patients with Clonal Hematopoiesis
    Patel, Shyam Ajay
    Gerber, William K.
    Zheng, Rena
    Khanna, Shrinkhala
    Hutchinson, Lloyd
    Cerny, Jan
    Dasilva, Brandon
    Zhang, Tian Y.
    Khedr, Salwa
    Selove, William
    Woda, Bruce
    Abel, Gregory A.
    Miron, Patricia Minehart
    Higgins, Anne
    Gerber, Jonathan M.
    BLOOD, 2023, 142
  • [28] Similarities and Differences of DNMT3A, TET2 and ASXL1 Mutations across Ccus, MDS and AML
    Huber, Sandra
    Hutter, Stephan
    Baer, Constance Regina
    Meggendorfer, Manja
    Hoermann, Gregor
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2024, 144 : 1820 - 1820
  • [29] Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations
    Segura-Diaz, Adrian
    Stuckey, Ruth
    Florido, Yanira
    Maria Gonzalez-Martin, Jesus
    Francisco Lopez-Rodriguez, Juan
    Sanchez-Sosa, Santiago
    Gonzalez-Perez, Elena
    Saez Perdomo, Maria Nieves
    del Mar Perera, Maria
    de la Iglesia, Silvia
    Molero-Labarta, Teresa
    Teresa Gomez-Casares, Maria
    Bilbao-Sieyro, Cristina
    CANCERS, 2020, 12 (04)
  • [30] MUTATIONS OF TET2, ASXL1, CBL AND IDH1 IN MYELOFIBROTIC TRANSFORMATION OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Aviles, L. Martinez
    Besses, C.
    Alvarez-Larran, A.
    Pons, A.
    Serrano, S.
    Bellosillo, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 403 - 403